Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income
AI Summary
StalkASML remains in a medium-term Stage 2 advance above its 200-day SMA but is digesting recent gains in a tight range between the 9/20 EMAs and the 50-day SMA, with neutral momentum and no active chart patterns, suggesting deferred mean-reversion entries on shallow pullbacks into the EMA zone while awaiting a decisive break above the 50-day SMA to confirm trend resumption.